Low Temperature Sterilization Market Size, Share & Trends Analysis Report By Product (Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers), By Device (Endoscopes, Ophthalmology, Laparoscopic Kit), By Region, And Segment Forecasts, 2025 - 2030

Low Temperature Sterilization Market Size, Share & Trends Analysis Report By Product (Ethylene Oxide Sterilizers, Hydrogen Peroxide Sterilizers), By Device (Endoscopes, Ophthalmology, Laparoscopic Kit), By Region, And Segment Forecasts, 2025 - 2030


E-liquid Market Growth & Trends

The global e-liquid market size is expected to reach USD 4.93 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.0% from 2025 to 2030. The advent of e-cigarette products such as squonk mods and pod systems has increased its popularity and adoption in recent years. The rising demand for these products globally is expected to drive the market over the forecast period. In addition, the general presumption that these products can reduce the risk of lung disorders is fueling the market. Moreover, the absence of the tobacco burning process that is often found in conventional smoking products is expected to drive the market in the near future.

The growing adoption of e-cigarettes among youngsters is escalating the market value of e-liquid. Owing to the absence of tobacco and the availability of various flavors, such as chocolate, menthol, blueberry, and a range of fruit flavors, the appeal, and acceptability of these products is expected to increase among non-smokers as well. The growing demand for e-cigarettes and vapes in the market can also be attributed to their minimal environmental footprint compared to traditional cigarette buds. As e-liquids are used in e-cigarettes and vaporizers, the producers are capitalizing on the trend of eco-friendly vaping, which is capturing consumer attention.

Market players are focusing on mergers and acquisitions, collaborations, and partnerships in order to expand their distribution networks and build an international presence for their brands. For instance, in January 2018, Nicopure, a manufacturer of e-cigarette and e-liquid, announced a partnership with Vapоr Ltd., a distributor of e-cigarette and e-liquid in Bulgaria. Nicopure appointed Vapоr Ltd. as one of its distributors in Bulgaria. The partnership allowed the former to expand its brand presence in Bulgaria.

Key players are increasingly investing in the marketing and distribution of their products owing to rising competition in the market. For instance, in July 2019, Turning Point Brands, Inc., a manufacturer, and distributor of consumer products, invested USD 3.0 million in the Canadian distribution firm ReCreation Marketing. Through the ReCreation Marketing platform, the company launched RipTide, an e-liquid vape technology, and a variety of Nu-X products in Canada.

E-liquid Market Report Highlights
  • In terms of flavor, the menthol segment is anticipated to register the highest growth rate over the forecast period owing to increasing adoption among young people, especially in students, coupled with its availability at affordable prices.
  • In terms of type, the bottled segment is expected to register growth at a significant pace from 2025 to 2030. This can be attributed to the fact that bottles allow users to make their own e-juice by adding two or more e-liquids.
  • In terms of distribution channel, the online segment is projected to grow at the highest CAGR during the forecast period due to increased accessibility, consumer awareness of vaping as a safer alternative to smoking, and a diverse range of product offerings.
  • In terms of region, North America e-liquid market dominated the global revenue with a revenue share of 39.5% in 2024. There is a well-established vaping culture and a strong distribution network that supports both online and retail sales.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Device
1.2.3. Regional Scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Low Temperature Sterilization Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Developments in Medical Devices
3.2.1.2. Increasing Investment for Sterilization Devices and Infrastructure
3.2.1.3. Expansion Into Emerging Economies
3.2.2. Market Restraint Analysis
3.2.2.1. Risks and Complications Associated With Different Sterilization Methods
3.3. Low Temperature Sterilization Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Low Temperature Sterilization Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
4.1. Low Temperature Sterilization Market: Product Outlook and Key Takeaways
4.2. Low Temperature Sterilization Market: Product Movement Analysis
4.3. Low Temperature Sterilization Market Estimates & Forecast, by Product (USD Million)
4.4. Ethylene Oxide Sterilizers
4.4.1. Ethylene Oxide Sterilizers Market, 2018 - 2030 (USD Million)
4.4.2. Hydrogen Peroxide Sterilizers
4.4.2.1. Hydrogen Peroxide Sterilizers Market, 2018 - 2030 (USD Million)
4.4.3. Others
4.4.3.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Low Temperature Sterilization Market - Segment Analysis, by Device, 2018 - 2030 (USD Million)
5.1. Low Temperature Sterilization Market: Device Outlook and Key Takeaways
5.2. Low Temperature Sterilization Market: Device Movement Analysis
5.3. Low Temperature Sterilization Market Estimates & Forecast, by Device Type (USD Million)
5.4. Endoscopes
5.4.1. Endoscopes Market, 2018 - 2030 (USD Million)
5.4.2. Flexible Endoscopes
5.4.2.1. Flexible Endoscopes Market, 2018 - 2030 (USD Million)
5.4.2.2. Single-Channel Flexible Endoscopes
5.4.2.2.1. Single-Channel Flexible Endoscopes Market, 2018 - 2030 (USD Million)
5.4.2.3. Dual-Channel Flexible Endoscopes
5.4.2.3.1. Dual-Channel Flexible Endoscopes Market, 2018 - 2030 (USD Million)
5.4.2.4. Triple-Channel Flexible Endoscopes
5.4.2.4.1. Triple-Channel Flexible Endoscopes Market, 2018 - 2030 (USD Million)
5.4.3. Rigid Endoscopes
5.4.3.1. Rigid Endoscopes Market, 2018 - 2030 (USD Million)
5.4.3.2. Single-Channel Rigid Endoscopes
5.4.3.2.1. Single-Channel Rigid Endoscopes Market, 2018 - 2030 (USD Million)
5.4.3.3. Dual-Channel Rigid Endoscopes
5.4.3.3.1. Dual-Channel Rigid Endoscopes Market, 2018 - 2030 (USD Million)
5.5. Laparoscopy Kit
5.5.1. Laparoscopy Kit Market, 2018 - 2030 (USD Million)
5.6. Ophthalmology
5.6.1. Ophthalmology Market, 2018 - 2030 (USD Million)
5.7. Otolaryngology (ORL)
5.7.1. Otolaryngology (ORL) Market, 2018 - 2030 (USD Million)
5.8. Other Instruments
5.8.1. Other Instruments Market, 2018 - 2030 (USD Million)
Chapter 6. Low Temperature Sterilization Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.3. North America
6.3.1. U.S.
6.3.1.1. Key country dynamics
6.3.1.2. Regulatory framework/ reimbursement structure
6.3.1.3. Competitive scenario
6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Canada
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.3.3. Mexico
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Key country dynamics
6.4.1.2. Regulatory framework/ reimbursement structure
6.4.1.3. Competitive scenario
6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. France
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Italy
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Spain
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.4.6. Norway
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.4.8. Denmark
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. India
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Australia
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Argentina
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. UAE
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Kuwait
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Recent Developments & Impact Analysis by Key Market Participants
7.3. Company Market Share Analysis, 2024
7.4. Key Company Profiles
7.4.1. ASP Global (Fortive Corporation)
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Getinge
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. STERIS
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. Stryker
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. TDK Corporation
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. 3M
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Steelco S.p.A.
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Bionics Scientific (a Unit of Kartal Projects Pvt Ltd.)
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. DE LAMA S.P.A.
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Genist Technocracy Pvt. Ltd.
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Andersen Sterilizers
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Labotronics Scientific
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. Labtron Equipment Ltd
7.4.13.1. Company overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives
7.4.14. Qingdao Antech Scientific Co., Ltd.
7.4.14.1. Company overview
7.4.14.2. Financial performance
7.4.14.3. Product benchmarking
7.4.14.4. Strategic initiatives
7.4.15. Renosem
7.4.15.1. Company overview
7.4.15.2. Financial performance
7.4.15.3. Product benchmarking
7.4.15.4. Strategic initiatives
7.4.16. Scitek Global Co., Ltd.
7.4.16.1. Company overview
7.4.16.2. Financial performance
7.4.16.3. Product benchmarking
7.4.16.4. Strategic initiatives
7.4.17. SOLSTEO
7.4.17.1. Company overview
7.4.17.2. Financial performance
7.4.17.3. Product benchmarking
7.4.17.4. Strategic initiatives
7.4.18. Sterile Safequip And Chemicals Llp
7.4.18.1. Company overview
7.4.18.2. Financial performance
7.4.18.3. Product benchmarking
7.4.18.4. Strategic initiatives
7.4.19. Tuttnauer
7.4.19.1. Company overview
7.4.19.2. Financial performance
7.4.19.3. Product benchmarking
7.4.19.4. Strategic initiatives
7.4.20. HUMAN MEDITEK CO., LTD.
7.4.20.1. Company overview
7.4.20.2. Financial performance
7.4.20.3. Product benchmarking
7.4.20.4. Strategic initiatives
7.4.21. MMM Group
7.4.21.1. Company overview
7.4.21.2. Financial performance
7.4.21.3. Product benchmarking
7.4.21.4. Strategic initiatives
7.4.22. Canon Singapore Pte. Ltd.
7.4.22.1. Company overview
7.4.22.2. Financial performance
7.4.22.3. Product benchmarking
7.4.22.4. Strategic initiatives
7.4.23. INSTECH SYSTEMS
7.4.23.1. Company overview
7.4.23.2. Financial performance
7.4.23.3. Product benchmarking
7.4.23.4. Strategic initiatives
7.4.24. Biobase Biodusty (Shandong), Co., Ltd.
7.4.24.1. Company overview
7.4.24.2. Financial performance
7.4.24.3. Product benchmarking
7.4.24.4. Strategic initiatives
7.4.25. Telstar (Azbil Group)
7.4.25.1. Company overview
7.4.25.2. Financial performance
7.4.25.3. Product benchmarking
7.4.25.4. Strategic initiatives
7.4.26. Shinva Medical Instrument Co., Ltd.
7.4.26.1. Company overview
7.4.26.2. Financial performance
7.4.26.3. Product benchmarking
7.4.26.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings